Targeting PFAS and EDC Exposures to Improve Fertility in Idiopathic Infertile Couples

PFAS (per- and polyfluoroalkyl substances) are environmental chemicals of growing public health concern. Most of the US population is exposed to PFAS, but few know about the health implications or how to reduce exposure. This problem is accentuated in marginalized communities (i.e. rural, people of color, low income) who are more likely to have higher exposure to harmful chemicals and chronic disease, and less likely to have adequate health care. PFAS contribute to cardiometabolic risk factors and cardiovascular disease, including cardiac toxicity, vascular disorder, hypertension, dyslipidemia, and congenital heart disease, as well as myriad other adverse health effects. Phase I worked with rural residents and HCPs to develop an educational and actionable report-back (i.e., reporting of individual PFAS test results from a mail-in blood spot test) with clear and useful guidance for individuals and HCPs on how to reduce risk and monitor health conditions. This intervention will be tested in a Phase II randomized controlled trial to evaluate its efficacy/long-term effects in a larger population, including its use in a clinical setting for patients with high PFAS levels. Phase IIB will focus on scaling up and commercializing the mail-in test and report-back, including dissemination to rural, low income, and minority individuals.

Back to Award Directory